Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
5 Patents
#27 in Utrecht
#1,131 in Netherlands
Lava Therapeutics N.v.
Forward Citations = 5
13 inventors:
Lava Therapeutics N.v.
Calculating rank
EPO Patents = 3
Trademarks = 3
Forward Citations = 5
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Johannes Jelle Van Der Vliet (5 out of 7 patents)
Tanja Denise De Gruijl (4 out of 8 patents)
Renée Cornelia Gerarda De Bruin (3 out of 5 patents)
4. Hendrik Marinus Willem Verheul (3 out of 5 patents)
5. Roeland Lameris (3 out of 4 patents)
6. Paul Willem Henri Ida Parren (2 out of 2 patents)
7. Robertus Cornelis Roovers (1 out of 6 patents)
8. Peter Alexander Gerardus Maria Machielsen (1 out of 1 patent)
9. Victoria Iglesias Guimarais (1 out of 1 patent)
10. Lisa Anna King (1 out of 1 patent)
11. Iris De Weerdt (1 out of 1 patent)
12. Arnon Philip Kater (1 out of 1 patent)
13. David Lutje Hulsik (1 out of 1 patent)
14. Roland Lameris (0 patent)
5 patents:
Company Overview
Lava Therapeutics N.V. is a clinical-stage biotechnology company focused on developing a new class of T cell engagers for the treatment of cancer. The company's proprietary technology platform is designed to harness the power of the immune system to target and eliminate cancer cells. Lava's lead product candidates are based on its unique approach to T cell engagement, aiming to improve the efficacy and safety of cancer therapies. The company is committed to advancing innovative treatments that can significantly impact patient outcomes in oncology.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lava Therapeutics N.v.. Retrieved from https://idiyas.com/company/lava-therapeutics-n-v
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]